World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
28664
World Ranking
15000
National Ranking
7583

Overview

Russell E. Ware is affiliated with Cincinnati Children's Hospital Medical Center in the United States. Their academic contributions primarily focus on medicine, with a strong emphasis on genetics, hematology, pediatrics, perinatology and child health, public health, environmental and occupational health, and molecular biology.

The scientist's research centers heavily on hemoglobinopathies and related disorders, iron metabolism and disorders, myeloproliferative neoplasms including diagnosis and treatment, blood groups and transfusion, prenatal screening and diagnostics, blood donation and transfusion practices, and malaria research and control.

Frequent publication venues where Ware's research appears include:

  • Blood
  • British Journal of Haematology
  • Blood Advances
  • Pediatric Blood & Cancer
  • American Journal of Hematology

Recent papers authored by Ware or with their contribution include:

  • Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa, 2020, New England Journal of Medicine
  • Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission, 2023, The Lancet Haematology
  • Empowering newborn screening programs in African countries through establishment of an international collaborative effort, 2020, Journal of Community Genetics
  • Effective use of hydroxyurea for sickle cell anemia in low-resource countries, 2020, Current Opinion in Hematology
  • Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease, 2021, British Journal of Haematology

Russell E. Ware has collaborated frequently with several researchers, including Teresa Latham, Susan E. Stuber, Adam Lane, Luke R. Smart, and Charles T. Quinn.

Best Publications

  • Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members

    Barbara P. Yawn;George R. Buchanan;Araba N. Afenyi-Annan;Samir K. Ballas

  • Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

    Charles Parker;Mitsuhiro Omine;Stephen Richards;Jun-Ichi Nishimura

  • Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

    Winfred C Wang;Russell E Ware;Scott T Miller;Rathi V Iyer

  • Safety of Hydroxyurea in Children With Sickle Cell Anemia: Results of the HUG-KIDS Study, a Phase I/II Trial

    Thomas R. Kinney;Ronald W. Helms;Erin E. O’Branski;Kwaku Ohene-Frempong

  • A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

    Elliott Vichinsky;Carolyn C. Hoppe;Kenneth I. Ataga;Russell E. Ware

  • Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial.

    Andrea Amalfitano;A. Resai Bengur;Richard P. Morse;Joseph M. Majure

  • How I use Hydroxyurea to treat Young Patients with Sickle Cell Anemia

    Russell E. Ware

  • Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huet anomaly)

    Katrin Hoffmann;Katrin Hoffmann;Christine K. Dreger;Ada L. Olins;Donald E. Olins

  • Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).

    Russell E. Ware;Ronald W. Helms

  • Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management

    Karina Yazdanbakhsh;Russell E. Ware

  • R2* magnetic resonance imaging of the liver in patients with iron overload

    Jane S. Hankins;M. Beth McCarville;Ralf B. Loeffler;Matthew P. Smeltzer

  • Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease

    Sherri A. Zimmerman;William H. Schultz;Jacqueline S. Davis;Chrisley V. Pickens

  • Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia - TCD with Transfusions Changing to Hydroxyurea (TWiTCH): A multicentre, open-label, phase 3, non-inferiority trial

    Russell E. Ware;Barry R Davis;William H. Schultz;R. Clark Brown

  • Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan.

    Jun-Ichi Nishimura;Yuzuru Kanakura;Russell E. Ware;Tsutomu Shichishima

  • Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia

    Michael R. DeBaun;F. Daniel Armstrong;Robert C. McKinstry;Russell E. Ware

  • Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study.

    Jane S. Hankins;Russell E. Ware;Zora R. Rogers;Lynn W. Wynn

  • Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa

    Léon Tshilolo;George Tomlinson;Thomas N. Williams;Brígida Santos

  • Impact of hydroxyurea on clinical events in the BABY HUG trial

    Courtney D. Thornburg;Beatrice A. Files;Zhaoyu Luo;Scott T. Miller

  • In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology

    Michelle Tsai;Ashley Kita;Joseph Leach;Ross Rounsevell

  • The molecular basis of paroxysmal nocturnal hemoglobinuria.

    WF Rosse;RE Ware

Frequent Co-Authors

Winfred C. Wang
Winfred C. Wang St. Jude Children's Research Hospital
Thomas N. Williams
Thomas N. Williams Imperial College London
Barry R. Davis
Barry R. Davis The University of Texas Health Science Center at Houston
Punam Malik
Punam Malik Cincinnati Children's Hospital Medical Center
George Tomlinson
George Tomlinson University of Toronto
Elliott Vichinsky
Elliott Vichinsky University of California, San Francisco
Alex Sparreboom
Alex Sparreboom The Ohio State University
Stephen D. Dertinger
Stephen D. Dertinger University of Rochester
David H.K. Chui
David H.K. Chui Boston University
Joanne Kurtzberg
Joanne Kurtzberg Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare careers beyond traditional medical school, there are several affordable online pathways to consider. Those who are detail-oriented and seeking an administrative role may benefit from earning a medical coding certification, which enables entry into the growing field of health information management.

Nursing is another rewarding pathway with multiple online degree options. Many aspiring nurse practitioners seek out the cheapest online fnp programs to help minimize student debt while advancing their clinical expertise. For registered nurses looking to move up the career ladder, searching for the cheapest online msn programs can be a smart step toward specialization or leadership roles.

Additionally, those interested in teaching, research, or high-level nursing administration might consider online doctoral studies. There are several doctorate in nursing education online programs that combine flexibility with academic rigor, making advanced education more accessible than ever.

Best Scientists Citing Russell E. Ware

Trending Scientists